![]() |
Volumn 76, Issue 4, 2001, Pages 966-974
|
A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents
|
Author keywords
Anticancer agents; Blood brain barrier; Drug delivery systems; Large neutral amino acid transporter; Melphalan; P glycoprotein
|
Indexed keywords
ACIVICIN;
ANTINEOPLASTIC AGENT;
GLYCOPROTEIN;
LEUCINE;
MELPHALAN;
TRACER;
VERAPAMIL;
AMINO ACID TRANSPORT;
AMINO TERMINAL SEQUENCE;
ANIMAL TISSUE;
ARTICLE;
BLOOD BRAIN BARRIER;
BRAIN BLOOD VESSEL;
BRAIN METABOLISM;
BRAIN PERFUSION;
CAPILLARY WALL;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG STRUCTURE;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
AMINO ACID TRANSPORT SYSTEMS;
AMINO ACIDS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BINDING, COMPETITIVE;
BLOOD-BRAIN BARRIER;
BRAIN;
CARRIER PROTEINS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG CARRIERS;
ISOXAZOLES;
MALE;
MELPHALAN;
P-GLYCOPROTEIN;
PERFUSION;
PRODRUGS;
RADIOACTIVE TRACERS;
RATS;
RATS, SPRAGUE-DAWLEY;
VERAPAMIL;
ANIMALIA;
|
EID: 0035116415
PISSN: 00223042
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1471-4159.2001.00031.x Document Type: Article |
Times cited : (20)
|
References (30)
|